Legacy Capital Group California, Inc. Gilead Sciences, Inc. Transaction History
Legacy Capital Group California, Inc.
- $361 Billion
- Q2 2025
A detailed history of Legacy Capital Group California, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Legacy Capital Group California, Inc. holds 5,829 shares of GILD stock, worth $656,870. This represents 0.18% of its overall portfolio holdings.
Number of Shares
5,829
Previous 5,967
2.31%
Holding current value
$656,870
Previous $669 Million
3.34%
% of portfolio
0.18%
Previous 0.23%
Shares
10 transactions
Others Institutions Holding GILD
# of Institutions
2,330Shares Held
1.02BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$13.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$13.5 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$6.67 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.22 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.23 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $141B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...